• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌细胞 microRNA-150 赋予心脏保护作用,并直接抑制促凋亡的富含脯氨酸的小分子蛋白 1A。

Cardiomyocyte microRNA-150 confers cardiac protection and directly represses proapoptotic small proline-rich protein 1A.

机构信息

Department of Anatomy, Cell Biology and Physiology, and.

Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

出版信息

JCI Insight. 2021 Sep 22;6(18):e150405. doi: 10.1172/jci.insight.150405.

DOI:10.1172/jci.insight.150405
PMID:34403363
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8492334/
Abstract

MicroRNA-150 (miR-150) is downregulated in patients with multiple cardiovascular diseases and in diverse mouse models of heart failure (HF). miR-150 is significantly associated with HF severity and outcome in humans. We previously reported that miR-150 is activated by β-blocker carvedilol (Carv) and plays a protective role in the heart using a systemic miR-150 KO mouse model. However, mechanisms that regulate cell-specific miR-150 expression and function in HF are unknown. Here, we demonstrate that potentially novel conditional cardiomyocyte-specific (CM-specific) miR-150 KO (miR-150 cKO) in mice worsens maladaptive cardiac remodeling after myocardial infarction (MI). Genome-wide transcriptomic analysis in miR-150 cKO mouse hearts identifies small proline-rich protein 1a (Sprr1a) as a potentially novel target of miR-150. Our studies further reveal that Sprr1a expression is upregulated in CMs isolated from ischemic myocardium and subjected to simulated ischemia/reperfusion, while its expression is downregulated in hearts and CMs by Carv. We also show that left ventricular SPRR1A is upregulated in patients with HF and that Sprr1a knockdown in mice prevents maladaptive post-MI remodeling. Lastly, protective roles of CM miR-150 are, in part, attributed to the direct and functional repression of proapoptotic Sprr1a. Our findings suggest a crucial role for the miR-150/SPRR1A axis in regulating CM function post-MI.

摘要

微小 RNA-150(miR-150)在患有多种心血管疾病的患者和心力衰竭(HF)的多种小鼠模型中下调。miR-150 与人类 HF 的严重程度和预后显著相关。我们之前报道过,miR-150 被β受体阻滞剂卡维地洛(Carv)激活,并在使用全身性 miR-150 KO 小鼠模型时在心脏中发挥保护作用。然而,调节 HF 中细胞特异性 miR-150 表达和功能的机制尚不清楚。在这里,我们证明了在小鼠中潜在的新型条件性心肌细胞特异性(CM 特异性)miR-150 KO(miR-150 cKO)可加重心肌梗死后的适应性心脏重构。miR-150 cKO 小鼠心脏的全基因组转录组分析确定小脯氨酸丰富蛋白 1a(Sprr1a)为 miR-150 的潜在新型靶标。我们的研究进一步表明,Sprr1a 在从缺血心肌分离并进行模拟缺血/再灌注的 CMs 中表达上调,而在 Carv 处理的心脏和 CMs 中表达下调。我们还表明,SPRRA 在 HF 患者的左心室中上调,并且在小鼠中 Sprr1a 的敲低可防止适应性心肌梗死后重构。最后,CM miR-150 的保护作用部分归因于促凋亡 Sprr1a 的直接和功能性抑制。我们的研究结果表明,miR-150/SRR1A 轴在调节 MI 后 CM 功能方面起着至关重要的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/6fbcb371c093/jciinsight-6-150405-g202.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/5d1a71323e84/jciinsight-6-150405-g195.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/497c25ba1799/jciinsight-6-150405-g196.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/d8e6d4a9ea29/jciinsight-6-150405-g197.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/45bbcece4163/jciinsight-6-150405-g198.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/0ec74dedbedf/jciinsight-6-150405-g199.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/9d863ef131d3/jciinsight-6-150405-g200.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/ee9333898de4/jciinsight-6-150405-g201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/6fbcb371c093/jciinsight-6-150405-g202.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/5d1a71323e84/jciinsight-6-150405-g195.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/497c25ba1799/jciinsight-6-150405-g196.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/d8e6d4a9ea29/jciinsight-6-150405-g197.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/45bbcece4163/jciinsight-6-150405-g198.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/0ec74dedbedf/jciinsight-6-150405-g199.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/9d863ef131d3/jciinsight-6-150405-g200.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/ee9333898de4/jciinsight-6-150405-g201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d485/8492334/6fbcb371c093/jciinsight-6-150405-g202.jpg

相似文献

1
Cardiomyocyte microRNA-150 confers cardiac protection and directly represses proapoptotic small proline-rich protein 1A.心肌细胞 microRNA-150 赋予心脏保护作用,并直接抑制促凋亡的富含脯氨酸的小分子蛋白 1A。
JCI Insight. 2021 Sep 22;6(18):e150405. doi: 10.1172/jci.insight.150405.
2
SPRR1A is a key downstream effector of MiR-150 during both maladaptive cardiac remodeling in mice and human cardiac fibroblast activation.SPRR1A 是 miR-150 在小鼠和人心肌成纤维细胞激活的病理性心脏重构中的一个关键下游效应因子。
Cell Death Dis. 2023 Jul 19;14(7):446. doi: 10.1038/s41419-023-05982-y.
3
MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic .miR-150 通过长链非编码 RNA MIAT 减轻病理性心脏重构并直接抑制成纤维细胞增殖
Circ Heart Fail. 2022 Apr;15(4):e008686. doi: 10.1161/CIRCHEARTFAILURE.121.008686. Epub 2022 Jan 10.
4
MicroRNA-150 Deletion from Adult Myofibroblasts Augments Maladaptive Cardiac Remodeling Following Chronic Myocardial Infarction.成年成肌纤维细胞中MicroRNA-150缺失加剧慢性心肌梗死后的适应性不良心脏重塑。
Biomolecules. 2024 Dec 22;14(12):1650. doi: 10.3390/biom14121650.
5
MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death.微小RNA-150通过调节细胞死亡保护小鼠心脏免受缺血性损伤。
Cardiovasc Res. 2015 Jun 1;106(3):387-97. doi: 10.1093/cvr/cvv121. Epub 2015 Mar 30.
6
A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.一种可被卡维地洛响应的 microRNA,miR-125b-5p,通过抑制心肌细胞中的促凋亡 bak1 和 klf13,保护心脏免受急性心肌梗死的影响。
J Mol Cell Cardiol. 2018 Jan;114:72-82. doi: 10.1016/j.yjmcc.2017.11.003. Epub 2017 Nov 7.
7
LncRNA HIF1A-AS1 contributes to ventricular remodeling after myocardial ischemia/reperfusion injury by adsorption of microRNA-204 to regulating SOCS2 expression.长链非编码 RNA HIF1A-AS1 通过吸附 microRNA-204 来调节 SOCS2 表达,从而促进心肌缺血/再灌注损伤后的心室重构。
Cell Cycle. 2019 Oct;18(19):2465-2480. doi: 10.1080/15384101.2019.1648960. Epub 2019 Aug 5.
8
microRNA-30e up-regulation alleviates myocardial ischemia-reperfusion injury and promotes ventricular remodeling via SOX9 repression.microRNA-30e 的上调通过抑制 SOX9 减轻心肌缺血再灌注损伤并促进心室重构。
Mol Immunol. 2021 Feb;130:96-103. doi: 10.1016/j.molimm.2020.11.009. Epub 2020 Dec 5.
9
Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.卡维地洛反应性微小RNA,即miR-199a-3p和-214可保护心肌细胞免受模拟缺血再灌注损伤。
Am J Physiol Heart Circ Physiol. 2016 Aug 1;311(2):H371-83. doi: 10.1152/ajpheart.00807.2015. Epub 2016 Jun 10.
10
Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice.MicroRNA-9-5p 的抑制可防止心肌梗死后小鼠的心脏重构。
Hum Gene Ther. 2019 Mar;30(3):286-301. doi: 10.1089/hum.2018.059. Epub 2018 Oct 31.

引用本文的文献

1
Noncoding RNAs in myocardial ischemia/reperfusion injury and repair.非编码RNA在心肌缺血/再灌注损伤与修复中的作用
Curr Opin Physiol. 2025 Jun;44. doi: 10.1016/j.cophys.2025.100825. Epub 2025 Mar 21.
2
Epigenetic Mechanisms in Heart Diseases.心脏病中的表观遗传机制
Rev Cardiovasc Med. 2025 Jul 30;26(7):38696. doi: 10.31083/RCM38696. eCollection 2025 Jul.
3
Cardiomyocyte Janus kinase 1 (JAK1) signaling is required for cardiac homeostasis and cytokine-dependent activation of STAT3.心肌细胞中的Janus激酶1(JAK1)信号传导是心脏内环境稳态和细胞因子依赖性STAT3激活所必需的。

本文引用的文献

1
High SPRR1A expression is associated with poor survival in patients with colon cancer.SPRR1A高表达与结肠癌患者的不良生存相关。
Oncol Lett. 2020 May;19(5):3417-3424. doi: 10.3892/ol.2020.11453. Epub 2020 Mar 10.
2
Transcriptomics and metabolomics reveal the cardioprotective effect of Compound Danshen tablet on isoproterenol-induced myocardial injury in high-fat-diet fed mice.转录组学和代谢组学揭示复方丹参片对高脂饮食喂养的异丙肾上腺素诱导心肌损伤的心脏保护作用。
J Ethnopharmacol. 2020 Jan 10;246:112210. doi: 10.1016/j.jep.2019.112210. Epub 2019 Aug 31.
3
Identification of Candidate Genes Involved in Renal Ischemia/Reperfusion Injury.
J Mol Cell Cardiol. 2025 Jul 29;207:13-23. doi: 10.1016/j.yjmcc.2025.07.017.
4
Periostin is a Pivotal Target of microRNA-150-5p in Cardiac Fibroblast Activation and Chronic Myocardial Infarction.骨膜蛋白是微小RNA-150-5p在心肌成纤维细胞激活和慢性心肌梗死中的关键靶点。
JACC Basic Transl Sci. 2025 Jul 25;10(8):101330. doi: 10.1016/j.jacbts.2025.101330.
5
Obesity and Heart Failure: Mechanistic Insights and the Regulatory Role of MicroRNAs.肥胖与心力衰竭:机制洞察及微小RNA的调节作用
Genes (Basel). 2025 May 28;16(6):647. doi: 10.3390/genes16060647.
6
Cardiomyocyte-restricted MIAT deletion is sufficient to protect against murine myocardial infarction.心肌细胞特异性MIAT缺失足以预防小鼠心肌梗死。
Cell Death Discov. 2025 Feb 20;11(1):70. doi: 10.1038/s41420-025-02352-9.
7
MicroRNA-150 Deletion from Adult Myofibroblasts Augments Maladaptive Cardiac Remodeling Following Chronic Myocardial Infarction.成年成肌纤维细胞中MicroRNA-150缺失加剧慢性心肌梗死后的适应性不良心脏重塑。
Biomolecules. 2024 Dec 22;14(12):1650. doi: 10.3390/biom14121650.
8
Lifestyle-Driven Variations in Nutrimiromic MicroRNA Expression Patterns across and beyond Genders.跨性别及不同性别之外由生活方式驱动的营养基因组学微小RNA表达模式变化
Life (Basel). 2024 Mar 15;14(3):390. doi: 10.3390/life14030390.
9
Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease.非编码RNA作为缺血性心脏病的治疗靶点和生物标志物
Nat Rev Cardiol. 2024 Aug;21(8):556-573. doi: 10.1038/s41569-024-01001-5. Epub 2024 Mar 18.
10
Inhibition of myocardial remodeling through miR-150/TET3 axis after AMI.AMI 后通过 miR-150/TET3 轴抑制心肌重构。
Mol Biol Rep. 2023 Dec 28;51(1):32. doi: 10.1007/s11033-023-08932-1.
鉴定与肾缺血/再灌注损伤相关的候选基因。
DNA Cell Biol. 2019 Mar;38(3):256-262. doi: 10.1089/dna.2018.4551. Epub 2019 Jan 22.
4
A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.一种可被卡维地洛响应的 microRNA,miR-125b-5p,通过抑制心肌细胞中的促凋亡 bak1 和 klf13,保护心脏免受急性心肌梗死的影响。
J Mol Cell Cardiol. 2018 Jan;114:72-82. doi: 10.1016/j.yjmcc.2017.11.003. Epub 2017 Nov 7.
5
MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition.MicroRNA-532 对急性心肌梗死有心脏保护作用,可抑制 prss23,后者是内皮细胞向间充质转化的正向调节因子。
Cardiovasc Res. 2017 Nov 1;113(13):1603-1614. doi: 10.1093/cvr/cvx132.
6
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine.治疗性微小RNA和小干扰RNA:作为新一代药物从实验室走向临床
Mol Ther Nucleic Acids. 2017 Sep 15;8:132-143. doi: 10.1016/j.omtn.2017.06.005. Epub 2017 Jun 12.
7
Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study.循环微小RNA-150-5p作为晚期心力衰竭的新型生物标志物:一项全基因组前瞻性研究。
J Heart Lung Transplant. 2017 Jun;36(6):616-624. doi: 10.1016/j.healun.2017.02.008. Epub 2017 Feb 11.
8
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.微小 RNA 治疗学:癌症和其他疾病治疗新时代的到来。
Nat Rev Drug Discov. 2017 Mar;16(3):203-222. doi: 10.1038/nrd.2016.246. Epub 2017 Feb 17.
9
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.一项关于MRX34(一种脂质体包裹的miR-34a模拟物)的I期研究,该药物在晚期实体瘤患者中每周给药两次。
Invest New Drugs. 2017 Apr;35(2):180-188. doi: 10.1007/s10637-016-0407-y. Epub 2016 Dec 5.
10
Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.卡维地洛反应性微小RNA,即miR-199a-3p和-214可保护心肌细胞免受模拟缺血再灌注损伤。
Am J Physiol Heart Circ Physiol. 2016 Aug 1;311(2):H371-83. doi: 10.1152/ajpheart.00807.2015. Epub 2016 Jun 10.